Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Bristol-Myers Squibb
Meletios A Dimopoulos; Dominik Dytfeld; Sebastian Grosicki; Philippe Moreau; Naoki Takezako; Mitsuo Hori; Xavier Leleu; Richard LeBlanc; Kenshi Suzuki; Marc S Raab; Paul G Richardson; Mihaela Popa McKiver; Ying-Ming Jou; Suresh G Shelat; Michael Robbins; Brian Rafferty; Jesús San-Miguel